Cargando…

Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial

BACKGROUND: Sparse data on the safety of pyronaridine-artesunate after repeated treatment of malaria episodes restrict its clinical use. We therefore compared the safety of pyronaridine-artesunate after treatment of the first episode of malaria versus re-treatment in a substudy analysis. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sagara, Issaka, Beavogui, Abdoul Habib, Zongo, Issaka, Soulama, Issiaka, Borghini-Fuhrer, Isabelle, Fofana, Bakary, Camara, Daouda, Somé, Anyirékun F, Coulibaly, Aboubacar S, Traore, Oumar B, Dara, Niawanlou, Kabore, Moïse J T, Thera, Ismaila, Compaore, Yves D, Sylla, Malick Minkael, Nikiema, Frederic, Diallo, Mamadou Saliou, Dicko, Alassane, Gil, Jose Pedro, Borrmann, Steffen, Duparc, Stephan, Miller, Robert M, Doumbo, Ogobara K, Shin, Jangsik, Bjorkman, Anders, Ouedraogo, Jean-Bosco, Sirima, Sodiomon B, Djimdé, Abdoulaye A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Science ;, The Lancet Pub. Group 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726763/ https://www.ncbi.nlm.nih.gov/pubmed/26601738 http://dx.doi.org/10.1016/S1473-3099(15)00318-7

Ejemplares similares

Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso
por: Compaoré, Yves Daniel, et al.
Publicado: (2021)

Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method
por: Funck-Brentano, Christian, et al.
Publicado: (2019)

Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso
por: Beshir, Khalid B., et al.
Publicado: (2021)

Efficacy of artemether-lumefantrine and artesunate-amodiaquine as first line therapy of uncomplicated malaria in Burkina Faso, 11 years after policy change
por: Zongo, Issaka, et al.
Publicado: (2020)

Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2016)

Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients
por: Ayyoub, Amal, et al.
Publicado: (2016)

Haematological and Biochemical Reference Values for Healthy Population of Maferinyah Rural Community in Guinea
por: Béavogui, Abdoul Habib, et al.
Publicado: (2020)

Efficacy, Safety and Tolerability of Pyronaridine-artesunate in Asymptomatic Malaria-infected Individuals: a Randomized Controlled Trial
por: Dabira, Edgard D, et al.
Publicado: (2021)

Plasmodium falciparum msp1 and msp2 genetic diversity and allele frequencies in parasites isolated from symptomatic malaria patients in Bobo-Dioulasso, Burkina Faso
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2018)

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali
por: Tekete, Mamadou, et al.
Publicado: (2009)

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali and Niger
por: Somé, Anyirékun Fabrice, et al.
Publicado: (2022)

Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali
por: Cairns, Matthew E., et al.
Publicado: (2020)

Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children
por: Djimde, Abdoulaye A., et al.
Publicado: (2016)

Pharmacokinetic Interaction between Pyronaridine-Artesunate and Metoprolol
por: Morris, Carrie A., et al.
Publicado: (2014)

Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact
por: Sagara, Issaka, et al.
Publicado: (2012)

Seasonal Malaria Chemoprevention Implementation: Effect on Malaria Incidence and Immunity in a Context of Expansion of P. falciparum Resistant Genotypes with Potential Reduction of the Effectiveness in Sub-Saharan Africa
por: Nikiema, Séni, et al.
Publicado: (2022)

Nutritional status in young children prior to the malaria transmission season in Burkina Faso and Mali, and its impact on the incidence of clinical malaria
por: de Wit, Mariken, et al.
Publicado: (2021)

Review of pyronaridine anti-malarial properties and product characteristics
por: Croft, Simon L, et al.
Publicado: (2012)

Impact of Plasmodium falciparum infection on DNA methylation of circulating immune cells
por: Almojil, Dareen, et al.
Publicado: (2023)

Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali
por: Djimde, Moussa, et al.
Publicado: (2019)

Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
por: Inoue, Juliana, et al.
Publicado: (2018)

Drug-Drug Interaction Analysis of Pyronaridine/Artesunate and Ritonavir in Healthy Volunteers
por: Morris, Carrie A., et al.
Publicado: (2012)

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children
por: Chotsiri, Palang, et al.
Publicado: (2019)

Impact of seasonal RTS,S/AS01(E) vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali
por: Grant, Jane, et al.
Publicado: (2022)

Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali
por: Fofana, Bakary, et al.
Publicado: (2022)

Genetic Diversity of Polymorphic Vaccine Candidate Antigens (Apical Membrane Antigen-1, Merozoite Surface Protein-3, and Erythrocyte Binding Antigen-175) in Plasmodium falciparum Isolates from Western and Central Africa
por: Soulama, Issiaka, et al.
Publicado: (2011)

Effectiveness of pyronaridine-artesunate against Plasmodium malariae, Plasmodium ovale spp, and mixed-Plasmodium infections: a post-hoc analysis of the CANTAM-Pyramax trial
por: Groger, Mirjam, et al.
Publicado: (2022)

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
por: Ouologuem, Dinkorma T., et al.
Publicado: (2018)

Serotype Profile of Nasopharyngeal Isolates of Streptococcus pneumoniae Obtained from Children in Burkina Faso before and after Mass Administration of Azithromycin
por: Hema-Ouangraoua, Soumeya, et al.
Publicado: (2020)

Antibodies to malaria vaccine candidates are associated with chloroquine or sulphadoxine/pyrimethamine treatment efficacy in children in an endemic area of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Clinical Variation of Plasmodium falciparum eba-175, ama-1, and msp-3 Genotypes in Young Children Living in a Seasonally High Malaria Transmission Setting in Burkina Faso
por: Soulama, Issiaka, et al.
Publicado: (2015)

The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali
por: Phiri, Mphatso Dennis, et al.
Publicado: (2021)

The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01(E) Malaria Vaccine( )
por: Sagara, Issaka, et al.
Publicado: (2021)

Assessment of the transmission blocking activity of antimalarial compounds by membrane feeding assays using natural Plasmodium falciparum gametocyte isolates from West-Africa
por: B. Henry, Noëlie, et al.
Publicado: (2023)

Lessons learned from the use of HRP-2 based rapid diagnostic test in community-wide screening and treatment of asymptomatic carriers of Plasmodium falciparum in Burkina Faso
por: Tiono, Alfred B, et al.
Publicado: (2014)

Pyronaridine–artesunate real-world safety, tolerability, and effectiveness in malaria patients in 5 African countries: A single-arm, open-label, cohort event monitoring study
por: Tona Lutete, Gaston, et al.
Publicado: (2021)

Seasonal malaria vaccination: protocol of a phase 3 trial of seasonal vaccination with the RTS,S/AS01(E) vaccine, seasonal malaria chemoprevention and the combination of vaccination and chemoprevention
por: Chandramohan, Daniel, et al.
Publicado: (2020)

Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: a qualitative study in the health district of Kaya, Burkina Faso
por: Hien, Denise, et al.
Publicado: (2022)

Prevalence of malaria and factors associated with infection in children aged 6 months to 9 years in Guinea: Results from a national cross-sectional study
por: Beavogui, Abdoul Habib, et al.
Publicado: (2020)

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso
por: Diarra, Amidou, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_g8643144nj0r3eoeet0pkt16vr